day 2 of tirzepatide 2, Let's do this! , Got any questions? Please ask @heydokitami.., #fyp #foryoupage #foryou #weightlosstransformation #tirzepatide Scientists Report: A 4‑Hour Timing

In developing the CKM management framework, it is also important to identify and develop strategies to address therapeutic inertia for the use of evidence-based therapies for optimal care

In this study, patients with HIV and MASLD over the age of 18 whose viral load, or the amount of HIV in the blood, was suppressed to undetectable levels by antiretroviral therapy (ART)

TRPV1 (Transient Receptor Potential Vanilloid 1) is a non-selective cation channel, also known as the capsaicin receptor or vanilloid receptor 1

All treatment decisions should be made individually, taking into account your medical history, existing conditions, and current medications.